Human alpha interferon (IFN) significantly inhibits the replication of herpes simplex virus type 1 in human neuroblastoma cells. This inhibitory effect can be blocked by pretreatment with antiserum to IFN. We observed no significant differences in the expression of major nucleocapsid proteins, including VP5, between IFN-treated and untreated Previously, we have shown that human interferons (HuIFNs) can block HSV replication in human fibroblast and monkey kidney cells (8, 11) . The molecular mechanism of interferon (IFN) action on the DNA viruses, specifically on HSV, is not well understood. Reports from other laboratories have shown that HuIFNs prevent the replication of HSV (15, 20, 21) , although the modes of action in various cell lines and with different types and preparations of IFNs were not identical. Furthermore, it is not known whether IFNs act in a similar fashion against HSV in cells of neuronal origin, a site for establishment of latency.
Herpes simplex viruses (HSV) are among the most extensively studied animal viruses which cause asymptomatic to life-threatening diseases. Productive infections by HSV result in virus multiplication and cell death. In addition to this type of acute infection, HSV can become latent in the body of a host and often reactivates, causing serious problems. Latency is established at the level of dorsal root ganglia (1, 2) . Recently, significant efforts have been made to prevent reactivation of HSV infections by treatment with antiviral drugs, although only one has had clinical success (12, 25) .
Previously, we have shown that human interferons (HuIFNs) can block HSV replication in human fibroblast and monkey kidney cells (8, 11) . The molecular mechanism of interferon (IFN) action on the DNA viruses, specifically on HSV, is not well understood. Reports from other laboratories have shown that HuIFNs prevent the replication of HSV (15, 20, 21) , although the modes of action in various cell lines and with different types and preparations of IFNs were not identical. Furthermore, it is not known whether IFNs act in a similar fashion against HSV in cells of neuronal origin, a site for establishment of latency.
In this report, we show that human alpha interferon (HuIFN-ot) inhibits the replication of HSV type 1 (HSV-1) in human neuroblastoma cells as effectively as in human foreskin fibroblast cells (8, 10) .
The expression of glycoprotein B (gB) and gE was greatly reduced in IFN-treated neuroblastoma cells, as determined by immunoblot assays. On the other hand, gD, although reduced in quantity, was expressed after IFN treatment and could be detected in the Golgi complexes and nuclear membranes, indicating that intracellular transport of this glycoprotein to the site of budding occurred normally. These results suggest that IFNs might be useful in the study of gene expression in IFN-treated human cells, including cells of neuronal origin, a target for establishment of latency.
In order to determine the effect of HuIFN on the release of infectious HSV particles, neuroblastoma cells were pretreated with 0, 200, and 500 U of HuIFN- Since glycoproteins are functionally needed for envelopment of nucleocapsids and budding from nuclear membranes, we examined whether the block in production of infectious virus particles was due to a defect in the expression of glycoproteins. The same cell lysates that were used in the experiment described above were analyzed by immunoblotting to assess the expression of gB, gD, and gE, using monoclonal antibodies. Figure 3A shows that, unlike the levels of nucleocapsid proteins, the levels of gB and gE were greatly reduced in IFN-treated neuroblastoma cells. (Fig. 3B) . Furthermore, the viral particles released from treated cells almost totally lacked gD and gE. In parallel, one set of pellets was processed for a dot blot assay in order to determine the total levels of extracellular viral particles released. The nitrocellulose blot was reacted with rabbit antiserum to HSV-1. It is clear that detectable quantities of particles (14 and 18% as determined by gamma counting) were released from cells treated with IFN (200 and 500 U/ml, respectively) (Fig. 4) . In addition, electron microscopic observations demonstrated the release of extracellular HSV-1 particles from IFN-treated cells (data not shown).
Although extracellular viral particles lacked gD, we showed that IFN-treated neuroblastoma cells expressed appreciable amounts of gD (Fig. 3A) . However, it was not possible to determine the location of this glycoprotein inside the IFN-treated cells or the reason for the possible block in incorporation of gD into viral particles by immunoblotting. An indirect immunofluorescence experiment was performed to detect the location of gD in cells treated with IFN (200 and 500 U/ml). The immunofluorescence assay confirmed the presence of gD within the IFN-treated cells (Fig. 5) . The location of gD inside the treated cells was also determined by rhodamine labeling, which indicated that there was precise expression of gD in Golgi complexes, as we found in untreated cells (Fig. 5 ). In addition, perinuclear staining of gD in IFN-treated cells was also prominent (Fig. 5) Sahni and Samuel (24) showed that the synthesis of vesicular stomatitis virus protein G is significantly inhibited in transfected COS cells treated with IFN. Several species of virus-specific glycoproteins (gB, gC, gD, gE, gG, gH, and gI) have been detected in HSV-infected cells (3, 13, 16, 18, 19, 23) , although only gB, gD, and gH are essential for virus infectivity (14) . Previously, we found that the expression of gB and gD is greatly reduced in IFNtreated human fibroblast and monkey kidney cells (8, 11) . However, the expression of these glycoproteins is different in neuroblastoma cells than it is in human fibroblast cells. In neuroblastoma cells, although the expression of gD was somewhat reduced, gD was expressed after IFN treatment. We also studied the expression of gE in IFN-treated neuroblastoma cells. This glycoprotein is known to be responsible for the induction of Fc-binding activity on virusinfected cells (3) and has been reported to be involved in HSV-1-induced cell fusion (9) . As Fig. 3A shows, the expression of gE was greatly reduced in IFN-treated human neuroblastoma cells. Extracellular viral particles released from IFN-treated cells totally lacked this glycoprotein, as expected. It is important to note that, even in control cells, the amount of gE expressed on the virus particles was very small. It is not known whether the HSV-1 particles produced from human neuroblastoma cells expressed little gE or this was due to some other reason.
In this study we found that HuIFN-a significantly blocks HSV-1 replication in human neuroblastoma cells, which means that IFN could be useful in preventing reactivation of HSV-1 infections in human cells of neuronal origin. Our results suggest that HuIFN-a may be useful for studying HSV glycoprotein expression and transport in human neuronal and other cells. Thus, future studies with IFN should contribute to a detailed understanding of HSV morphogenesis in human cells.
